Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin
Alzheimer’s disease (AD), the most common form of dementia, is characterized by amyloid-β (Aβ) accumulation, microglia-associated neuroinflammation, and synaptic loss. The detailed neuropathologic characteristics in early-stage AD, however, are largely unclear. We evaluated the pathologic brain alte...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f374323079340529d0aaedd0f68f9b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0f374323079340529d0aaedd0f68f9b4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0f374323079340529d0aaedd0f68f9b42021-11-25T17:13:24ZMicroglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin10.3390/cells101132612073-4409https://doaj.org/article/0f374323079340529d0aaedd0f68f9b42021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3261https://doaj.org/toc/2073-4409Alzheimer’s disease (AD), the most common form of dementia, is characterized by amyloid-β (Aβ) accumulation, microglia-associated neuroinflammation, and synaptic loss. The detailed neuropathologic characteristics in early-stage AD, however, are largely unclear. We evaluated the pathologic brain alterations in young adult App knock-in model <i>App<sup>NL-G-F</sup></i> mice at 3 and 6 months of age, which corresponds to early-stage AD. At 3 months of age, microglia expression in the cortex and hippocampus was significantly decreased. By the age of 6 months, the number and function of the microglia increased, accompanied by progressive amyloid-β deposition, synaptic dysfunction, neuroinflammation, and dysregulation of β-catenin and NF-κB signaling pathways. The neuropathologic changes were more severe in female mice than in male mice. Oral administration of dioscin, a natural product, ameliorated the neuropathologic alterations in young <i>App<sup>NL-G-F</sup></i> mice. Our findings revealed microglia-based sex-differential neuropathologic changes in a mouse model of early-stage AD and therapeutic efficacy of dioscin on the brain lesions. Dioscin may represent a potential treatment for AD.Xiao LiuQian ZhouJia-He ZhangKe-Yong WangTakashi SaitoTakaomi C. SaidoXiaoying WangXiumei GaoKagaku AzumaMDPI AGarticleAlzheimer’s disease<i>A</i><i>pp<sup>NL-G-F</sup></i>dioscinamyloid-βsynaptic dysfunctionmicrogliaBiology (General)QH301-705.5ENCells, Vol 10, Iss 3261, p 3261 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Alzheimer’s disease <i>A</i><i>pp<sup>NL-G-F</sup></i> dioscin amyloid-β synaptic dysfunction microglia Biology (General) QH301-705.5 |
spellingShingle |
Alzheimer’s disease <i>A</i><i>pp<sup>NL-G-F</sup></i> dioscin amyloid-β synaptic dysfunction microglia Biology (General) QH301-705.5 Xiao Liu Qian Zhou Jia-He Zhang Ke-Yong Wang Takashi Saito Takaomi C. Saido Xiaoying Wang Xiumei Gao Kagaku Azuma Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin |
description |
Alzheimer’s disease (AD), the most common form of dementia, is characterized by amyloid-β (Aβ) accumulation, microglia-associated neuroinflammation, and synaptic loss. The detailed neuropathologic characteristics in early-stage AD, however, are largely unclear. We evaluated the pathologic brain alterations in young adult App knock-in model <i>App<sup>NL-G-F</sup></i> mice at 3 and 6 months of age, which corresponds to early-stage AD. At 3 months of age, microglia expression in the cortex and hippocampus was significantly decreased. By the age of 6 months, the number and function of the microglia increased, accompanied by progressive amyloid-β deposition, synaptic dysfunction, neuroinflammation, and dysregulation of β-catenin and NF-κB signaling pathways. The neuropathologic changes were more severe in female mice than in male mice. Oral administration of dioscin, a natural product, ameliorated the neuropathologic alterations in young <i>App<sup>NL-G-F</sup></i> mice. Our findings revealed microglia-based sex-differential neuropathologic changes in a mouse model of early-stage AD and therapeutic efficacy of dioscin on the brain lesions. Dioscin may represent a potential treatment for AD. |
format |
article |
author |
Xiao Liu Qian Zhou Jia-He Zhang Ke-Yong Wang Takashi Saito Takaomi C. Saido Xiaoying Wang Xiumei Gao Kagaku Azuma |
author_facet |
Xiao Liu Qian Zhou Jia-He Zhang Ke-Yong Wang Takashi Saito Takaomi C. Saido Xiaoying Wang Xiumei Gao Kagaku Azuma |
author_sort |
Xiao Liu |
title |
Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin |
title_short |
Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin |
title_full |
Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin |
title_fullStr |
Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin |
title_full_unstemmed |
Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin |
title_sort |
microglia-based sex-biased neuropathology in early-stage alzheimer’s disease model mice and the potential pharmacologic efficacy of dioscin |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/0f374323079340529d0aaedd0f68f9b4 |
work_keys_str_mv |
AT xiaoliu microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT qianzhou microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT jiahezhang microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT keyongwang microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT takashisaito microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT takaomicsaido microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT xiaoyingwang microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT xiumeigao microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin AT kagakuazuma microgliabasedsexbiasedneuropathologyinearlystagealzheimersdiseasemodelmiceandthepotentialpharmacologicefficacyofdioscin |
_version_ |
1718412573108338688 |